Analysis using the U133Plus gene expressions expands this result by including JUN (JUN oncogene), MAPK8 (mitogen activated protein kinase 8), SRC (v-SRC sarcoma) and FYN (FYN oncogene related to SRC) as protein kinases within dasatinib’s discriminating genes. This evidence concerns the gene MAPK8 and sarcoma.